Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 November 2022 |
Main ID: |
NCT03497481 |
Date of registration:
|
06/04/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Neopterin Dosage in the Eye
CHA |
Scientific title:
|
Appreciation of the Possibility of Dosing Neopterin in Eye Liquids. Pilot Study of Neopterin Dosage in Eye Liquids. |
Date of first enrolment:
|
June 22, 2018 |
Target sample size:
|
20 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03497481 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Anélia Benarrosh, doctor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer |
|
Name:
|
Chaker Nefzaoui, doctor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age = 18 years-old
- Non inflammatory or non infectious ophthalmic pathology requiring puncture of eye's
anterior chamber fluid.
- Minimum of 200 microliter sample
- Immunocompetent subjects
- Signed and dated informed consent
- Samples management in accordance with the pre-analytical conditions specified in the
protocol
Non-inclusion criteria:
- Age < 18 years-old
- Subjects treated with intraocular corticoids, antibiotics or anti-inflammatory,
locally or in systemic injection, prior to inclusion.
Exclusion Criteria:
- Subjects who exercised his right of withdrawal
- Study suspended on principal investigator, sponsor or health authorities' demand.
- Deceased subjects
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Cataract
|
Intervention(s)
|
Biological: Samples
|
Primary Outcome(s)
|
Detection and dosage of neopterin in the eye
[Time Frame: 3 month]
|
Secondary Outcome(s)
|
False positives identification and elimination.
[Time Frame: 3 month]
|
Neopterin concentration comparison between study values and reference value.
[Time Frame: 3 month]
|
Secondary ID(s)
|
2017-A00183-47
|
2017-CHITS-02
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|